Sanofi (SNY) has released an update ... TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

the French state and CD&R and was approved by Sanofi’s board on Sunday, the newspaper said. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news ...

Sanofi (NASDAQ:SNY – Free Report) by 30.4% during the third quarter, according to the company in its most recent filing with ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Sanofi is scheduled to report results for the third quarter on ... Dow Jones Newswires Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers ...

including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in Sanofi’s annual report on Form 20-F for the year ended December 31 ...

Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented, “The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...

Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab ... will be presented in 23 abstracts at ...

Sanofi is deepening its commitment to targeted ... according to the company’s annual report. The bulk of the revenue was from back end operations that include recycling used fuel, making storage ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the third quarter ...